+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

HIV preventive vaccine research at the ANRS: the lipopeptide vaccine approach

Therapie 60(3): 243-248

HIV preventive vaccine research at the ANRS: the lipopeptide vaccine approach

The HIV (human immunodeficiency virus)/AIDS epidemic is of unprecedented gravity and is spreading rapidly, notably in the most disadvantaged regions of the world. The search for a preventive vaccine is thus an absolute priority. For over 10 years the ANRS (Agence Nationale de Recherches sur le SIDA) has been committed to an original programme combining basic science and clinical research.

(PDF same-day service: $19.90)

Accession: 012135976

PMID: 16128266

DOI: 10.2515/therapie:2005031

Related references

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. Aids 24(14): 2211-2223, 2011

Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16). Vaccine 31(40): 4406-4415, 2014

Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. Advances in Experimental Medicine and Biology 611: 347-349, 2009

Considerations regarding efficacy endpoints in HIV vaccine trials: executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine Enterprise. Vaccine 27(14): 1989-1996, 2009

Preventive vaccinations in children; antiwhooping cough-diptheria vaccine; antidiphtheria vaccine. Revista Chilena de Pediatria 21(4): 170-5; Contd, 1950

New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours. Bmj 316(7140): 1317-1318, 1998

Influenza vaccine: an effective preventive vaccine for developing countries. Human Vaccines & Immunotherapeutics 8(5): 675-678, 2013

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. Journal of Infectious Diseases 191(5): 666-677, 2005

A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene. Molecular Medicine Reports 4(5): 885-890, 2011

Compared clinical tolerance and immunogenicity of the typhim Vi vaccine associated with the DT vaccine and the TAB vaccine, combined with the DT vaccine, in primary vaccination and after a booster dose, in military environment (Morocco). Revue Internationale des Services de Sante des Forces Armees 70(4-6): 94-96, 98-100, 1997